Search Results for: FORMULATION DEVELOPMENT Interactive Web Tool


- 5/23/2012

Agilent to Acquire Cancer Diagnostic Company for $2.2 Billion Agilent Technologies Inc. and EQT, the Sweden-based private equity group, recently...

- SPECIAL FEATURE- Analytical Testing of Biologics & Biosimilars

Contributor Cindy H. Dubin talks with some of the leading experts in the industry about the importance of outsourcing analytical testing in the biologic/biosimilar space, the associated challenges, and how to ensure products get to market safely and quickly.